4.4 Article

Association of age, hormonal, and lifestyle factors with the Leydig cell biomarker INSL3 in aging men from the European Male Aging Study cohort

Related references

Note: Only part of the references are listed.
Review Endocrinology & Metabolism

Expression and Role of INSL3 in the Fetal Testis

Richard Ivell et al.

Summary: INSL3 is a peptide hormone produced and secreted by fetal Leydig cells in the testes. It acts through the RXFP2 receptor to promote testis descent in male fetuses and serves as an important biomarker for Leydig cell differentiation. Maternal exposure to endocrine disrupting chemicals may reduce INSL3 levels and lead to cryptorchidism.

FRONTIERS IN ENDOCRINOLOGY (2022)

Editorial Material Endocrinology & Metabolism

Insulin-like Factor 3 Emerges from the Shadow of Testosterone as a Leydig Cell Biomarker

Jorma Toppari

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

Serum Insulin-like Factor 3 Levels Are Reduced in Former Androgen Users, Suggesting Impaired Leydig Cell Capacity

Jon Jarlov Rasmussen et al.

Summary: The study found that serum INSL3 concentrations were lower in AAS users compared to non-users, even years after cessation. This suggests a persistent impairment of Leydig cell function due to AAS, independent of testosterone levels.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Andrology

Male seminal parameters are not associated with Leydig cell functional capacity in men

Ravinder Anand-Ivell et al.

Summary: The study found that INSL3 concentration was not related to any semen parameter, but was negatively correlated with BMI. IN both cohorts, there was a significant relationship between INSL3 and FSH, but not LH concentration. Additionally, INSL3 was not correlated with androgen receptor trinucleotide repeat polymorphisms or the T/LH ratio.

ANDROLOGY (2021)

Review Biochemistry & Molecular Biology

Relaxin in hepatic fibrosis: What is known and where to head?

Devaraj Ezhilarasan

Summary: RLX is a polypeptide hormone with natural anti-fibrotic activity in various organs, including the liver. By activating RLX receptors, it can reduce hepatic fibrosis and promote extracellular matrix remodeling to inhibit fibrosis.

BIOCHIMIE (2021)

Article Endocrinology & Metabolism

Dynamic Interactions Between LH and Testosterone in Healthy Community-Dwelling Men: Impact of Age and Body Composition

Ferdinand Roelfsema et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Endocrinology & Metabolism

Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function

Jakob Albrethsen et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Obstetrics & Gynecology

Age-related changes in human Leydig cell status

Valentina Mularoni et al.

HUMAN REPRODUCTION (2020)

Article Medical Laboratory Technology

Development and validation of a mass spectrometry-based assay for quantification of insulin-like factor 3 in human serum

Jakob Albrethsen et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)

Review Endocrinology & Metabolism

Hypogonadism and male obesity: Focus on unresolved questions

Mathis Grossmann

CLINICAL ENDOCRINOLOGY (2018)

Article Endocrinology & Metabolism

Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline

Shalender Bhasin et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)

Article Endocrinology & Metabolism

Elevated luteinizing hormone despite normal testosterone levels in older mennatural history, risk factors and clinical features

Robert J. A. H. Eendebak et al.

CLINICAL ENDOCRINOLOGY (2018)

Review Pharmacology & Pharmacy

Relaxin-like peptides in male reproduction - a human perspective

Richard Ivell et al.

BRITISH JOURNAL OF PHARMACOLOGY (2017)

Review Reproductive Biology

INSL3 as a Biomarker of Leydig Cell Functionality

Richard Ivell et al.

BIOLOGY OF REPRODUCTION (2013)

Article Public, Environmental & Occupational Health

Cohort Profile: The European Male Ageing Study

David M. Lee et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)

Article Medicine, General & Internal

Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men

Frederick C. W. Wu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Obstetrics & Gynecology

Biology of insulin-like factor 3 in human reproduction

Richard Ivell et al.

HUMAN REPRODUCTION UPDATE (2009)

Article Andrology

The European Male Ageing Study (EMAS): design, methods and recruitment

David M. Lee et al.

INTERNATIONAL JOURNAL OF ANDROLOGY (2009)

Article Cell Biology

The aging male hypothalamic-pituitary-gonadal axis: Pulsatility and feedback

Johannes D. Veldhuis et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)

Article Biotechnology & Applied Microbiology

Androgen-forming stem Leydig cells: Identification, function and therapeutic potential

Yunhui Zhang et al.

DISEASE MARKERS (2008)

Article Endocrinology & Metabolism

Mutations in the insulin-like factor 3 receptor are associated with osteoporosis

Alberto Ferlin et al.

JOURNAL OF BONE AND MINERAL RESEARCH (2008)

Article Andrology

Peripheral INSL3 concentrations decline with age in a large population of Australian men

Ravinder Anand-Ivell et al.

INTERNATIONAL JOURNAL OF ANDROLOGY (2006)

Article Biochemistry & Molecular Biology

Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women

Fernand Labrie et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)

Article Endocrinology & Metabolism

Impaired Leydig cell function in infertile men:: A study of 357 idiopathic infertile men and 318 proven fertile controls

AM Andersson et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)

Review Endocrinology & Metabolism

Inhibin B in male reproduction: pathophysiology and clinical relevance

SJ Meachem et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2001)